Indian vaccine against cervical cancer: What you need to know
1/5
SII to launch vaccine
Cervical cancer is the second most frequent cancer among women between 15 and 44 years of age. Now, the Serum Institute of India is planning to launch its indigenously-developed vaccine to treat cervical cancer.
2/5
Cervavac will be affordable
SII says Cervavac, the Indian HPV vaccine to treat cervical cancer in women will be both affordable and accessible. It has received market authorisation from the Drugs Controller General of India (DCGI)
3/5
India's first vaccine
The Quadrivalent Human Papillomavirus vaccine (qHPV), which is India's first vaccine against HPV, could be out later this year, according to SII CEO Adar Poonawalla.
Amazon Top Deals
POWERED BY
atomberg Studio Smart+ 1200mm BLDC Ceiling Fan with IoT & Remote | BEE 5 star Rated Energy Efficient Ceiling Fan | High Air Delivery with LED Indicators | 3 Year Warranty (Earth Brown)
₹5,882Buy Now36%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹19,340Buy Now19%
OFF
4/5
How it occurs
Cervical cancer occurs in the cells of the cervix — the lower part of the uterus. It's mostly caused by various strains of HPV, which is sexually transmitted.
5/5
Approvals done
The DCGI's approval for Cervavac comes following recommendation by the Subject Expert Committee (SEC) . The government advisory panel NTAGI had recently also approved the qHPV after reviewing the clinical trial data.